F11R is a novel monocyte prognostic biomarker for malignant glioma

Pong, W.W., Walker, J., Wylie, T., Magrini, V., Luo, J., Emnett, R.J., Choi, J., Cooper, M.L., Griffith, M., Griffith, O.L., Rubin, J.B., Fuller, G.N., Piwnica-Worms, D., Feng, X., Hambardzumyan, D., DiPersio, J.F., Mardis, E.R., Gutmann, D.H.; (2013) PLoS ONE, 8 (10), art. no. e77571 Read More

Abstract

Objective:Brain tumors (gliomas) contain large populations of infiltrating macrophages and recruited microglia, which in experimental murine glioma models promote tumor formation and progression. Among the barriers to understanding the contributions of these stromal elements to high-grade glioma (glioblastoma; GBM) biology is the relative paucity of tools to characterize infiltrating macrophages and resident microglia. In this study, we leveraged multiple RNA analysis platforms to identify new monocyte markers relevant to GBM patient outcome.Methods:High-confidence lists of mouse resident microglia- and bone marrow-derived macrophage-specific transcripts were generated using converging RNA-seq and microarray technologies and validated using qRT-PCR and flow cytometry. Expression of select cell surface markers was analyzed in brain-infiltrating macrophages and resident microglia in an induced GBM mouse model, while allogeneic bone marrow transplantation was performed to trace the origins of infiltrating and resident macrophages. Glioma tissue microarrays were examined by immunohistochemistry, and the Gene Expression Omnibus (GEO) database was queried to determine the prognostic value of identified microglia biomarkers in human GBM.Results:We generated a unique catalog of differentially-expressed bone marrow-derived monocyte and resident microglia transcripts, and demonstrated that brain-infiltrating macrophages acquire F11R expression in GBM and following bone-marrow transplantation. Moreover, mononuclear cell F11R expression positively correlates with human high-grade glioma and additionally serves as a biomarker for GBM patient survival, regardless of GBM molecular subtype.Significance:These studies establish F11R as a novel monocyte prognostic marker for GBM critical for defining a subpopulation of stromal cells for future potential therapeutic intervention. © 2013 Pong et al.

Full Text

.

EmailPrintShare
Posted on November 1, 2013
Posted in: Neurogenetics, Publications Authors: